Gilenya Cuts in Fall 2014

You know the launch history all too well. Another misfired NVS launch. Remember you ONlY get one shot to launch a drug and you need competent mgmt to do it right. Gilenya will always be step child in MS market........ Right up until until mgmt decides it's time to hold the sales force accountable for their mistakes and sends them through the chop shop.

 

Of course. The combo of Gilenya pathetic mgmt and Biogen eating our lunch, sales force moral is very low right now.

 

The Bold contest got me fired up. The chance to win 300 bucks to TJ Max makes me wanna work really hard. The drug is 50K a year and this is the dumb contest you come up who thinks of this shit. The Teva reps are still making more bonus then us.

 

It's over we are a 10% market share drug unless Tecfidera gets PML. Leadership blew another launch all the meetings,contests,segmentation won't change anything. I am only here because there is not much out there.

 

Leadership problems: They still think a primary care model sells a specialty drug. Fact: 3 1/2 years after launch and it is PROVEN the Novartis primary care model doesn't work.

Fact: Micro management and reach and frequency are not what moves market share. Clinical discussions and partnering with the dr's who write MS drugs moves market share. The primary care ABLS and RBDs still don't understand.

Fact: Sales team is checked out but little opportunity elsewhere. Why would Novartis management team enforce a non compete and want to hold on to employees that wish to leave. The employee doesn't want to work here and the employee stays and does a poor job.

There is no reason to continue to try to teach these idiots how to do their job. The PC mentality will not change and the 10% market share is here to stay. BTW - Management hates the 10% market share that is why they discuss the billion dollar drug. If we had the Techfidera market share that would be the 1st part Gilenya's success story

 

Dude, you spelled it out pretty dang close to reality.

 

Tecfidera will be $2 Billion in the US this year.

 

And Dagmar will sill get 500k in stock options for doing such a great job

 

Great job???

 

SOS the Gilenya ship is taken on of water and there will be lost lives within next 6 months. Moral is low and entire mgmt team is clueless and unmotivating.

 

Wow that was very insightful how long did it take you to think of that. Tell us something we don't know.

 

There will be no layoffs in MSBU any time soon. Established Medicines yes. But MSBU? Nah...

Fact 1. In 2015 Gilenya will get PPMS inducation, the only DMT with such an indication
Fact 2. In 2016 Gilenya will get CIPD indication
Fact 3. According to March 2014 settlement, Gilenya has patent protection through 2019
Fact 4. Novartis launching new molecule for MS in 2018
Fact 5. MSBU has less than 110 reps in the entire country. Very lean already.

So please quit spreading fears. You are in Specialty. Act like it! Yes we are micromanaged and leaders came from Primary Care. So they believe in reach and frequency. So what? Find another job making a base of 125k and bonus of 25-45k depending on performance, 75k bonus if you are in top 7 percent. You guys have it good. If this is a Biogen rep then enjoy your 3 person cluster while it lasts, how many Tec patients are you guys losing per month due to Diarrhea?

 

If you had any pride you would be embarrassed by a 10% market share. Does mirco management work? Does reach and frequency work in a specialty sale? 10% MARKET SHARE AT 3 1/2 YEARS ANSWERS THESE QUESTIONS.

 

Don't post the exception to the rule base pay of 125k. Several NVS internals switched over here as a lateral. That's right 0 increase in base pay. Most don't make above 80k base and this is fact. NVS looking to save money by bringing PCP internals over. They are also used to the PCP mgmt style.

 

Finally someone with a head posting on this thread. I agree! Both MS and Onc are the safest places to be both at Novartis and Industry wide. Derm too much of an unknown. Serelaxin dead. Established Meds is anything but. Alcon just had layoffs again. MS and Onc are the only good places right now

 

PPMS indication? yeah just like the cognition approval.

 

Somebody is responding to their own post here. Come on pal..... That is way weak!

 

With the industry loosing 40% of reps jobs over the last few years that isn't saying much.

 

and you think that sex scandals don't happen at NVS? open you eyes. Many males in senior positions routinely try to pick up associates within the company. Look, you're talking about Gilenya, look no further than the leadership managing this product!
If many of the senior staff were located in countries where woman have actual equal rights, there would a load of sexual harassment cases within this company.
But god forbid you talk to HR about this - they will cover the asses of the senior managers SO quickly and ensure that every last bit of it get's swept under the rug.